Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice
Open Access
- 7 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Brain
- Vol. 14 (1), 1-14
- https://doi.org/10.1186/s13041-020-00713-2
Abstract
Reduced expression of glutamate decarboxylase 67 (GAD67), encoded by the Gad1 gene, is a consistent finding in postmortem brains of patients with several psychiatric disorders, including schizophrenia, bipolar disorder and major depressive disorder. The dysfunction of GAD67 in the brain is implicated in the pathophysiology of these psychiatric disorders; however, the neurobiological consequences of GAD67 dysfunction in mature brains are not fully understood because the homozygous Gad1 knockout is lethal in newborn mice. We hypothesized that the tetracycline-controlled gene expression/suppression system could be applied to develop global GAD67 knockdown mice that would survive into adulthood. In addition, GAD67 knockdown mice would provide new insights into the neurobiological impact of GAD67 dysfunction. Here, we developed Gad1tTA/STOP−tetO biallelic knock-in mice using Gad1STOP−tetO and Gad1tTA knock-in mice, and compared them with Gad1+/+ mice. The expression level of GAD67 protein in brains of Gad1tTA/STOP−tetO mice treated with doxycycline (Dox) was decreased by approximately 90%. The GABA content was also decreased in the brains of Dox-treated Gad1tTA/STOP−tetO mice. In the open-field test, Dox-treated Gad1tTA/STOP−tetO mice exhibited hyper-locomotor activity and decreased duration spent in the center region. In addition, acoustic startle responses were impaired in Dox-treated Gad1tTA/STOP−tetO mice. These results suggest that global reduction in GAD67 elicits emotional abnormalities in mice. These GAD67 knockdown mice will be useful for elucidating the neurobiological mechanisms of emotional abnormalities, such as anxiety symptoms associated with psychiatric disorders.Keywords
Funding Information
- Japan Society for the Promotion of Science (26290002, 15H05872, 17H05550, 19K06881, 16H06276)
- Takeda Science Foundation
This publication has 51 references indexed in Scilit:
- Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depressionInternational Journal of Neuropsychopharmacology, 2009
- Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophreniaMolecular Psychiatry, 2007
- Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar DisorderArchives of General Psychiatry, 2000
- Decreased Glutamic Acid Decarboxylase67 Messenger RNA Expression in a Subset of Prefrontal Cortical γ-Aminobutyric Acid Neurons in Subjects With SchizophreniaArchives of General Psychiatry, 2000
- Synaptic localization of the 67,000 mol. wt isoform of glutamate decarboxylase and transmitter function of GABA in the mouse cerebellum lacking the 65,000 mol. wt isoformNeuroscience, 1999
- GABA and histogenesis in fetal and neonatal mouse brain lacking both the isoforms of glutamic acid decarboxylaseNeuroscience Research, 1999
- Two isoforms of glutamate decarboxylase: why?Trends in Pharmacological Sciences, 1998
- Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the formsJournal of Neuroscience, 1994
- Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brainJournal of Neuroscience, 1991
- Cofactor interactions and the regulation of glutamate decarboxylase activityNeurochemical Research, 1991